PREDICTION OF DRUG DISPOSITION BY HUMAN DRUG METABOLIZING ENZYMES
PREDICTION OF DRUG DISPOSITION BY HUMAN DRUG METABOLIZING ENZYMES
批准号:
11557191
负责人:
YAMAZAKI Hiroshi
金额:
$3.01万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Drug oxidation activities of twelve recombinant human cytochrome P450 (P450) coexpressed with human NADPH-P450 reductase (NPR) in bacterial membranes (P450/NPR membranes) were determined and compared with those of other recombinant systems and of human liver microsomes. Addition of exogenous membrane-bound NPR to the P450/NPR membranes enhanced the catalytic activities of CYP2C8, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 ; however, enhancement of activities of CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2D6, and CYP2E1 in membranes was not observed after the addition of NPR in 4-molar excess to each P450. Exogenous purified human cytochrome b_5 (b_5) further enhanced catalytic activities of CYP2A6, CYP2B6, CYP2C8, CYP2E1, CYP3A4, and CYP3A5/NPR membranes. Catalytic activities of CYP2C9 and CYP2C19 were enhanced by addition of b_5 in reconstitution systems but not in the P450/NPR membranes. Apo b_5 (devoid of heme) enhanced catalytic activities when added to the both systems, except for CYP2E1/NPR membranes and the reconstituted systems containing purified CYP2C8 or CYP2E1 in comparison with b_5. Catalytic activities in P450/NPR membranes plus b_5 systems were roughly similar to those measured with microsomes of insect cells coexpressing P450 with NPR (and b_5) and/or of human liver microsomes, based on equivalent P450 contents. These results suggest that interactions of P450 and NPR coexpressed in membranes and reconstituted systems appear to be different in some human CYP2 family enzymes, possibly due to a conformational role of b_5. P450/NPR membrane systems containing b_5 are useful models for prediction of the rates for liver microsomal P450-dependent drug oxidations.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nakajima M,et al.: "Azelastine N-demethylation by CYP3A4, CYP2D6, and CYP1A2 in human liver microsomes: Evaluation of approach to predict the contribution of multiple cytochrome P450s"Drug Metab Dispos. 27. 1381-1391 (1999)
Nakajima M 等人:“人肝微粒体中 CYP3A4、CYP2D6 和 CYP1A2 导致的氮卓斯汀 N-去甲基化:预测多种细胞色素 P450 贡献的方法评估”Drug Metab Dispos。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamazaki H,et al.: "Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P450 2C8 and P450 3A4 in human liver microsomes"Drug Metab Dispos. 27. 1260-1266 (1999)
Yamazaki H 等人:“人肝微粒体中细胞色素 P450 2C8 和 P450 3A4 催化曲格列酮氧化为醌型代谢物”Drug Metab Dispos。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
Relevance to bioactivation and toxicity of thalidomide, pomalidomide, and lenalidomide by human cytochrome P450 3A enzymes in cultured placental cells and humanized-liver mice
-
批准号:17K08425
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2017
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Mechanisms of resistance to molecularly targeted drugs for oral squamous cell carcinoma and investigation of countermeasures
-
批准号:16K11732
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2016
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Development of Effective Markers for Resistance of Oral Squamous Cell Carcinoma to Molecular-targeting Drugs
-
批准号:25463120
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2013
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Thalidomide increases cytochrome P450 activity and drug metabolism in liver through direct activation of nuclear receptor CAR and PXR
-
批准号:23590200
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2011
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
evaluationofeffectivenessoftheobjectiveexaminationforautism indeafchildren
-
批准号:22791642
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Role of cancer stem cells related molecules in oral squamous cell carcinoma
-
批准号:22592246
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Molecular mechanism of chemical-induced toxicity in fetal livers
-
批准号:17390034
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.07万
-
财政年份:2005
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Molecular Mechanisms of Toxic Expression Induced by Endocrine Disruptors via AHR
-
批准号:15390040
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:2003
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Study on the separation of rac and meso isomers and the reactivity of group 4 bridged metallocene complexes
-
批准号:11640544
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.38万
-
财政年份:1999
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Creation of Substitution Labile Pyrazolylborate Metal Complexes
-
批准号:09640675
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.96万
-
财政年份:1997
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
海外基金